(Q1)Jun 30, 2024 | (FY)Mar 31, 2024 | (Q4)Mar 31, 2024 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | (FY)Dec 31, 2021 | (Q4)Dec 31, 2021 | |
---|---|---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||||
Cash flow from continuing operating activities | -98.68%27.74K | 77.49%-3.74M | -354.09K | 160.10%2.1M | -16.63M | 133.44%157.53K | -957.18%-3.21M | -640.37%-3.5M | -7,042.60%-4.94M | -5,235.62%-3.7M |
Net income from continuing operations | 63.52%-1.06M | 40.01%-28.77M | ---20.02M | 37.84%-2.91M | ---47.96M | -2,342.40%-25.22M | -3,098.46%-3.78M | -889.74%-4.69M | -3,842.86%-5.29M | -2,865.22%-3.91M |
Operating gains losses | -464.29%-240.18K | 916.35%1.5M | --1.04M | 6,351.08%65.93K | --147.16K | --109.72K | 94.64%-30.78K | 477.40%1.02K | ---551.71K | --22K |
Depreciation and amortization | -25.14%302.54K | -22.82%1.54M | --375.12K | 12.31%404.13K | --2M | --163.21K | --380.6K | --359.84K | --156.01K | --156.01K |
Asset impairment expenditure | ---- | -62.49%9.55M | --9.55M | --0 | --25.46M | --25.13M | ---- | ---- | --0 | --0 |
Unrealized gains and losses of investment securities | ---- | 1,007.88%5.11M | --5.5M | ---- | --460.82K | ---- | ---- | ---- | ---- | ---- |
Remuneration paid in stock | 262.30%171.9K | -10.48%1.7M | --93.68K | -87.94%47.45K | --1.9M | ---65.22K | 231.06%280.02K | --393.53K | --193.81K | --109.23K |
Deferred tax | 55.09%-139.5K | 166.66%1.04M | --1.41M | -262.68%-310.64K | ---1.56M | ---528.23K | ---379.11K | --190.96K | --185.47K | --185.47K |
Other non cashItems | 13,514.21%79.51K | 3,720.42%175.13K | --174.54K | --584 | --4.58K | 141.38%1.8K | ---- | ---- | --1.61M | --1.62M |
Change In working capital | -80.67%921.3K | 72.71%4.2M | --1.69M | 1,824.23%4.77M | --2.43M | -59.72%227.92K | -111.59%-7.21K | 11,541.12%247.72K | -2,023.90%-1.25M | -3,105.72%-1.88M |
-Change in receivables | 135.70%488.78K | -99.13%4.22K | --108.16K | 8,740.42%207.37K | --486.22K | --82.05K | --409.55K | ---2.4K | --0 | --0 |
-Change in prepaid assets | -61.93%145.65K | -81.92%236.4K | --114.98K | 15.75%382.55K | --1.31M | ---451.98K | --530.98K | --330.49K | ---1.45M | ---1.45M |
-Change in payables and accrued expense | -74.82%272.41K | 596.95%3.51M | --1.49M | 1,445.91%1.08M | ---705.44K | -12.62%494.38K | -615.56%-320.53K | -3,876.55%-80.37K | 209.91%201.16K | -740.58%-428.93K |
-Change in other current assets | -98.52%14.47K | 52.85%1.09M | ---28.02K | --976.61K | --715.35K | ---- | ---- | ---- | --0 | --0 |
-Change in other working capital | ---- | -202.82%-643.79K | --4 | --2.12M | --626.13K | --843.11K | ---- | ---- | ---- | ---- |
Tax refund paid | -110.53%-4.42K | -55.59%219.14K | ---47.6K | --41.96K | --493.5K | ---- | ---- | ---- | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Operating cash flow | -98.68%27.74K | 77.49%-3.74M | ---354.09K | 160.10%2.1M | ---16.63M | 133.44%157.53K | -957.18%-3.21M | -640.37%-3.5M | -7,042.60%-4.94M | -5,235.62%-3.7M |
Investing cash flow | ||||||||||
Cash flow from continuing investing activities | 0 | 96.22%-138K | -2.11K | 101.14%14.77K | -3.65M | 2.07M | -3.2M | -1.29M | 406.17K | 406.17K |
Net PPE purchase and sale | --0 | 100.68%703 | ---2.11K | 110.30%2.77K | ---102.69K | ---29K | ---14.36K | ---26.85K | ---2.24K | ---2.24K |
Net business purchase and sale | ---- | 95.76%-150.7K | --0 | --0 | ---3.56M | --2.1M | ---3.19M | ---1.27M | --408.4K | --408.4K |
Net investment purchase and sale | --0 | 50.00%12K | --0 | 100.00%12K | --8K | ---4K | --0 | --6K | --0 | --0 |
Cash from discontinued investing activities | ||||||||||
Investing cash flow | --0 | 96.22%-138K | ---2.11K | 101.14%14.77K | ---3.65M | --2.07M | ---3.2M | ---1.29M | --406.17K | --406.17K |
Financing cash flow | ||||||||||
Cash flow from continuing financing activities | 445.27%52.31K | -3.39%3.15M | 326.55K | -15.15K | 3.26M | 94.84%-38.5K | 106.97%30.8K | 0 | 10,275.67%22.1M | 18.73M |
Net issuance payments of debt | -2,321.49%-366.88K | 2,164.71%3.11M | --243.02K | ---15.15K | ---150.62K | ---38.5K | ---- | ---- | --0 | --0 |
Net common stock issuance | --100K | -97.22%83.53K | ---- | ---- | --3M | ---- | --0 | --0 | --24.19M | --19.38M |
Proceeds from stock option exercised by employees | ---- | --0 | ---- | ---- | --18.95K | ---- | ---- | ---- | --0 | ---- |
Net other financing activities | --319.19K | -111.98%-46.58K | --0 | ---- | --388.85K | --0 | ---- | ---- | -1,082.62%-2.09M | ---652.15K |
Cash from discontinued financing activities | ||||||||||
Financing cash flow | 445.27%52.31K | -3.39%3.15M | --326.55K | ---15.15K | --3.26M | 94.84%-38.5K | 106.97%30.8K | --0 | 10,275.67%22.1M | 8,693.12%18.73M |
Net cash flow | ||||||||||
Beginning cash position | -96.28%27.1K | -95.87%727.97K | --115.11K | -95.87%727.97K | --17.63M | 93.07%6.48M | 206.49%12.81M | 12,791.79%17.63M | --136.75K | 3,316,195.52%2.22M |
Current changes in cash | -96.19%80.05K | 95.69%-734.17K | ---29.66K | 143.86%2.1M | ---17.02M | 279.80%2.19M | -756.54%-6.38M | -217.25%-4.79M | 12,114.49%17.56M | 10,642.48%15.44M |
Effect of exchange rate changes | -93.38%7.67K | -72.07%33.3K | ---58.35K | 490.95%115.96K | --119.2K | 103.67%165.65K | 170.72%54.47K | 30.34%-29.66K | -857.09%-67.12K | ---28.85K |
End cash Position | -96.10%114.82K | -96.28%27.1K | --27.1K | -77.01%2.94M | --727.97K | 80.74%4.02M | 93.07%6.48M | 206.49%12.81M | 12,791.79%17.63M | 12,791.79%17.63M |
Free cash from | -98.68%27.74K | 77.61%-3.75M | ---356.65K | 159.64%2.1M | ---16.73M | 127.28%128.52K | -961.91%-3.22M | -646.06%-3.52M | -7,045.83%-4.95M | -5,238.85%-3.7M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | Unqualified Opinion with Explanatory Notes | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data